David Solomon's Goldman Sachs Just Posted a Record $20.98 in Quarterly Earnings Per Share. Here's What Powered It.

Goldman Sachs reported record Q2 results, including revenue of $20.3B (+39% YoY) and EPS of $20.98, with global banking & markets revenue up 53% YoY as investment banking fees rose 55% YoY. Management attributes the surge to early innings of the AI cycle driving financing and risk-management demand, alongside heavier corporate dealmaking (large-cap M&A volume +90% YoY through 1H 2026). The stock’s valuation (~17x trailing-12-month earnings) is flagged as a potential late-cycle/peak-deal risk, but near-term momentum from a record backlog (highest in five years) remains supportive.

Analysis

The real signal is not one quarter of fees; it is how quickly capacity-constrained private-market issuance is turning into a recurring fee pool. That helps GS most in the near term because underwriting, restructuring and advisory carry very high operating leverage, but it also means the stock is now more exposed to a reversal in risk appetite than at any point in the last year. If the AI capex cycle stays hot, GS can keep monetizing financing and hedging needs; if volatility returns, that backlog can freeze fast.

Second-order winners are the enablers of the capital-spending cycle, not the bank itself. NVDA and infrastructure-heavy beneficiaries like NEE have more durable multi-year exposure if AI buildout really is early innings, while large corporates using balance-sheet actions or M&A can keep creating fee opportunities for GS and peers. The loser is the late-cycle investor who extrapolates a deal surge into a permanent earnings run-rate: IPO and M&A windows usually close faster than consensus models assume.

The contrarian risk is that the market is already paying for a peak tape in the capital-markets franchise. A 10-15% equity drawdown, a VIX spike, or any sign that backlog is converting more slowly would hit GS earnings estimates and justify multiple compression from current levels. Conversely, if next-quarter advisory revenue holds up and underwriting remains broad-based, the cycle-extension trade stays alive for 1-3 months; beyond 6-18 months, fee normalization is the more probable path.

Key Decisions for Investors

• Tactically long GS only on a pullback over the next 1-3 weeks; use the position as a momentum trade, not a core hold. Risk/reward is attractive if backlog converts, but trim aggressively if the stock re-rates above ~17-18x without new mandate wins.
• Pair trade: long NVDA / short GS for a 6-12 month view that AI monetization outlasts the deal cycle. The trade works if capex spending remains intact while underwriting fees mean-revert; stop if GS continues to post accelerating backlog and NVDA guidance slows.
• If you want capital-markets exposure with less peak-cycle risk, favor a basket long in NEE and GOOGL over GS on any weakness. These names can benefit from financing/M&A optionality without being as directly levered to IPO volume.
• Set an alert on GS for any 10%+ one-month drawdown or evidence that investment-banking fee growth decelerates materially next quarter; that is the cleanest falsifier for the bullish cycle thesis.